|Articles|June 6, 2018

Kayentis Partners With OmniComm

OmniComm Systems, Inc. announced a partnership with Kayentis that is focused on delivering OmniComm's EDC technology platform integrated with Kayentis' eCOA solutions to life sciences clients.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data

ByBrian S. McGowan, PhD, FACEHP,Kelly Ritch

September 16th 2026

How Clinical Teams Can Build Real Trust With Patient Advocacy Organizations

ByAmélie Lothe,Andy Studna, Senior Editor

September 16th 2026

ACT Brief: Epilepsy Trial Feasibility and Family Realities, CRO Partnerships and Strategic Value, and Cortisol and GLP-1 Response

ByAndy Studna, Senior Editor

September 16th 2026

Preclinical CROs are evolving from transactional vendors into strategic partners, with trust, talent, AI, and shared accountability driving value in 2026. Credit: Stock.Adobe.com/Gorodenkoff

The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026

ByPartha Anbil,Jayanthi Anbil

September 15th 2026

What the Epilepsy Community Has Taught Us About Trial Feasibility

ByAmélie Lothe,Andy Studna, Senior Editor

September 15th 2026

Trending on Applied Clinical Trials Online

The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026

The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver

What the Epilepsy Community Has Taught Us About Trial Feasibility

Predictive Clinical Development: Accelerating Success From Design to Delivery

ACT Brief: Epilepsy Trial Feasibility and Family Realities, CRO Partnerships and Strategic Value, and Cortisol and GLP-1 Response